Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 14, Issue 3, Pages 427-446
Publisher
Informa UK Limited
Online
2016-08-01
DOI
10.1080/17425247.2016.1218464
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances of cocktail chemotherapy by combination drug delivery systems
- (2016) Quanyin Hu et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of chemotherapeutics and proteins for synergistic therapy
- (2016) Chaoliang He et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of drugs and plasmid DNA for cancer therapy
- (2016) Pei Yun Teo et al. ADVANCED DRUG DELIVERY REVIEWS
- Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment
- (2016) Yu-Wei Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
- (2016) Jessica A. Kemp et al. ADVANCED DRUG DELIVERY REVIEWS
- Fabrication of dual responsive co-delivery system based on three-armed peptides for tumor therapy
- (2016) Si Chen et al. BIOMATERIALS
- A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy
- (2016) Shin-Yu Lee et al. BIOMATERIALS
- Polymer–iron oxide composite nanoparticles for EPR-independent drug delivery
- (2016) Jinho Park et al. BIOMATERIALS
- Time-staggered delivery of docetaxel and H1-S6A,F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting
- (2016) Lian Li et al. JOURNAL OF CONTROLLED RELEASE
- Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors
- (2016) Darren L. Stirland et al. JOURNAL OF CONTROLLED RELEASE
- Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy
- (2016) Yu Ren et al. JOURNAL OF CONTROLLED RELEASE
- Codelivery of a miR-124 Mimic and Obatoclax by Cholesterol-Penetratin Micelles Simultaneously Induces Apoptosis and Inhibits Autophagic Flux in Breast Cancer in Vitro and in Vivo
- (2016) Nan Zhang et al. MOLECULAR PHARMACEUTICS
- Drug Carriers: Not an Innocent Delivery Man
- (2015) Yoon Yeo et al. AAPS Journal
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- Self-Assembled Core–Shell Nanoparticles for Combined Chemotherapy and Photodynamic Therapy of Resistant Head and Neck Cancers
- (2015) Chunbai He et al. ACS Nano
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Structure-Invertible Nanoparticles for Triggered Co-Delivery of Nucleic Acids and Hydrophobic Drugs for Combination Cancer Therapy
- (2015) Kai Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Radiolabeled Polymeric Nanoconstructs Loaded with Docetaxel and Curcumin for Cancer Combinatorial Therapy and Nuclear Imaging
- (2015) Cinzia Stigliano et al. ADVANCED FUNCTIONAL MATERIALS
- Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy
- (2015) Song Shen et al. BIOMATERIALS
- Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer
- (2015) Ilkoo Noh et al. BIOMATERIALS
- Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy
- (2015) Xuejiao Song et al. BIOMATERIALS
- Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel
- (2015) Shan Tang et al. BIOMATERIALS
- Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer
- (2015) Tingjie Yin et al. BIOMATERIALS
- Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
- (2015) Rong Sun et al. BIOMATERIALS
- Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment
- (2015) Assogba G. Assanhou et al. BIOMATERIALS
- Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment
- (2015) Liqiong Cai et al. BIOMATERIALS
- Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells
- (2015) Hai Wang et al. BIOMATERIALS
- Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer
- (2015) Xiao Zhao et al. BIOMATERIALS
- Co-delivery of doxorubicin and tumor-suppressing p53 gene using a POSS-based star-shaped polymer for cancer therapy
- (2015) Yongmao Li et al. BIOMATERIALS
- Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
- (2015) P. Katsaounis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer
- (2015) Dawen Dong et al. CANCER LETTERS
- Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial
- (2015) Marcello Tiseo et al. Clinical Lung Cancer
- Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
- (2015) Jinwan Wang et al. Gastric Cancer
- Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin
- (2015) Lei Miao et al. JOURNAL OF CONTROLLED RELEASE
- Hybrid nanoparticles for combination therapy of cancer
- (2015) Chunbai He et al. JOURNAL OF CONTROLLED RELEASE
- Targeted delivery of platinum-taxane combination therapy in ovarian cancer
- (2015) Swapnil S. Desale et al. JOURNAL OF CONTROLLED RELEASE
- Hyperbranched–hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy
- (2015) Hui-Zhen Jia et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association
- (2015) Eunjung Lee et al. JOURNAL OF CONTROLLED RELEASE
- Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
- (2015) Xi-Chun Hu et al. LANCET ONCOLOGY
- Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma
- (2015) Haiqiang Cao et al. MOLECULAR PHARMACEUTICS
- Release Kinetics Study of Poorly Water-Soluble Drugs from Nanoparticles: Are We Doing It Right?
- (2015) Sara A. Abouelmagd et al. MOLECULAR PHARMACEUTICS
- Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane
- (2015) Qiang Fu et al. Nanoscale
- Programmable nanomedicine: synergistic and sequential drug delivery systems
- (2015) Dennis B. Pacardo et al. Nanoscale
- Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer
- (2015) Zelai He et al. TUMOR BIOLOGY
- Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
- (2015) Aaron Goldman et al. Nature Communications
- Site-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors
- (2015) Yaqiong Dong et al. Theranostics
- Concurrent Chemoradiotherapy with Vinorelbine plus Split-Dose Cisplatin may be an Option in Inoperable Stage III Non-Small Cell Lung Cancer: A Single-Center Experience
- (2015) Özgür Özyılkan MEDICAL SCIENCE MONITOR
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- Development of Both Methotrexate and Mitomycin C Loaded PEGylated Chitosan Nanoparticles for Targeted Drug Codelivery and Synergistic Anticancer Effect
- (2014) Mengmeng Jia et al. ACS Applied Materials & Interfaces
- Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
- (2014) Shutao Guo et al. ACS Nano
- Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
- (2014) Lei Miao et al. ADVANCED FUNCTIONAL MATERIALS
- Gel-Liposome-Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy
- (2014) Tianyue Jiang et al. ADVANCED FUNCTIONAL MATERIALS
- Furin-Mediated Sequential Delivery of Anticancer Cytokine and Small-Molecule Drug Shuttled by Graphene
- (2014) Tianyue Jiang et al. ADVANCED MATERIALS
- An Imagable and Photothermal “Abraxane-Like” Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors
- (2014) Qian Chen et al. ADVANCED MATERIALS
- Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
- (2014) Anupama Mittal et al. BIOMATERIALS
- Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer
- (2014) Shan Tang et al. BIOMATERIALS
- Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer
- (2014) Shixian Lv et al. BIOMATERIALS
- Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes
- (2014) Bojie Yu et al. BIOMATERIALS
- Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR
- (2014) Jie Shen et al. BIOMATERIALS
- Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer
- (2014) Xiongwei Deng et al. BIOMATERIALS
- PEGylated PAMAM dendrimer–doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy
- (2014) Xiaojie Li et al. BIOMATERIALS
- Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas
- (2014) Zhen-Zhen Yang et al. BIOMATERIALS
- Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core–shell nanoparticles
- (2014) Qiang Feng et al. BIOMATERIALS
- Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17)
- (2014) Y J Choi et al. BRITISH JOURNAL OF CANCER
- Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer
- (2014) Jian Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation
- (2014) Qian Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
- (2014) Elizabeth R. Plimack et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
- (2014) Nishant S. Gandhi et al. JOURNAL OF CONTROLLED RELEASE
- Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
- (2014) Sanjun Shi et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials
- (2014) G.V. Scagliotti et al. LUNG CANCER
- Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?
- (2014) V. L. Damaraju et al. MOLECULAR CANCER THERAPEUTICS
- Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
- (2014) Yarong Liu et al. MOLECULAR PHARMACEUTICS
- Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA
- (2014) Jianan Shen et al. MOLECULAR PHARMACEUTICS
- Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment
- (2014) Chia-Wei Su et al. Nanomedicine
- Amphiphilic copolymer coated upconversion nanoparticles for near-infrared light-triggered dual anticancer treatment
- (2014) Shun Yang et al. Nanoscale
- Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates
- (2014) R. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy
- (2014) Weicai Chen et al. Small
- Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram
- (2013) Xiaopin Duan et al. ACS Nano
- Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
- (2013) Huan Meng et al. ACS Nano
- Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects
- (2013) Wantong Song et al. Acta Biomaterialia
- Carboplatin/5-fluorouracil as an Alternative to Cisplatin/5-Fluorouracil for Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma
- (2013) Voon Fong Kua et al. Asian Pacific Journal of Cancer Prevention
- Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
- (2013) Xiaomin Qian et al. BIOMATERIALS
- Chemotherapy with cisplatin or carboplatin in combination with etoposide for small-cell esophageal cancer: a systemic analysis of case series
- (2013) R. Gao et al. DISEASES OF THE ESOPHAGUS
- Photodynamic nanomedicine in the treatment of solid tumors: Perspectives and challenges
- (2013) Alyssa Master et al. JOURNAL OF CONTROLLED RELEASE
- Progress in microRNA delivery
- (2013) Yu Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy
- (2013) Shutao Guo et al. JOURNAL OF CONTROLLED RELEASE
- Sequential Targeted Delivery of Paclitaxel and Camptothecin Using a Cross-Linked “Nanosponge” Network for Lung Cancer Chemotherapy
- (2013) Ghazal Hariri et al. MOLECULAR PHARMACEUTICS
- Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Antitumor Efficacy, and Drug-Induced Toxicity
- (2013) Amit K. Jain et al. MOLECULAR PHARMACEUTICS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance
- (2012) Haihua Xiao et al. BIOMATERIALS
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Deeper Penetration into Tumor Tissues and Enhanced in Vivo Antitumor Activity of Liposomal Paclitaxel by Pretreatment with Angiogenesis Inhibitor SU5416
- (2012) Yuta Yoshizawa et al. MOLECULAR PHARMACEUTICS
- Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
- (2012) Xiaomin Qian et al. MOLECULAR PHARMACEUTICS
- Red-Emitting Upconverting Nanoparticles for Photodynamic Therapy in Cancer Cells Under Near-Infrared Excitation
- (2012) Gan Tian et al. Small
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Drug delivery systems for differential release in combination therapy
- (2011) Hongbin Zhang et al. Expert Opinion on Drug Delivery
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Retinoids regulate stem cell differentiation
- (2010) Lorraine J. Gudas et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Small Upconverting Fluorescent Nanoparticles for Biomedical Applications
- (2010) Dev K. Chatterjee et al. Small
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- siRNA delivery systems for cancer treatment
- (2009) Yu-Kyoung Oh et al. ADVANCED DRUG DELIVERY REVIEWS
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
- (2009) Stephen Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
- (2009) Yogesh Patil et al. JOURNAL OF CONTROLLED RELEASE
- Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
- (2009) M. H. Cohen et al. ONCOLOGIST
- Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
- (2009) Masahiko Tanabe et al. Breast Cancer
- Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian Cancer
- (2008) Z. Lu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now